Cellular and Molecular Bioengineering

, Volume 1, Issue 1, pp 42–50

Mesenchymal Stem Cell Therapy for Protection and Repair of Injured Vital Organs

Authors

  • D. van Poll
    • Surgical Services and Center for Engineering in MedicineMassachusetts General Hospital, Harvard Medical School
    • Department of SurgeryUniversity Medical Center, University of Utrecht
  • B. Parekkadan
    • Surgical Services and Center for Engineering in MedicineMassachusetts General Hospital, Harvard Medical School
    • Harvard-MIT Division of Health Sciences and Technology
  • I. H. M. Borel Rinkes
    • Department of SurgeryUniversity Medical Center, University of Utrecht
  • A. W. Tilles
    • Surgical Services and Center for Engineering in MedicineMassachusetts General Hospital, Harvard Medical School
    • Surgical Services and Center for Engineering in MedicineMassachusetts General Hospital, Harvard Medical School
    • Harvard-MIT Division of Health Sciences and Technology
Article

DOI: 10.1007/s12195-008-0001-2

Cite this article as:
van Poll, D., Parekkadan, B., Borel Rinkes, I.H.M. et al. Cel. Mol. Bioeng. (2008) 1: 42. doi:10.1007/s12195-008-0001-2

Abstract

Recently there has been a paradigm shift in what is considered to be the therapeutic promise of mesenchymal stem cells (MSCs) in diseases of vital organs. Originally, research focused on MSCs as a source of regenerative cells by differentiation of transplanted cells into lost cell types. It is now clear that trophic modulation of inflammation, cell death, fibrosis, and tissue repair are the main mechanisms of MSC therapy. Delivery of growth factors, cytokines, and other signaling molecules secreted by MSCs is often sufficient to obtain the therapeutic effects. In this article, we provide an overview of the current knowledge on trophic mechanisms of MSC therapy in disease models of vital organs. Important issues regarding the optimal delivery methods of MSC therapy are discussed and critical gaps in our knowledge hampering experimental progress and clinical implementation are identified.

Keywords

Mesenchymal stem cells Cytokines Growth factors Injury Tissue injury Vital organs Liver Heart Kidney Lung Brain Regeneration Apoptosis Paracrine Angiogenesis Inflammation Immune cells Fulminant hepatic failure

Copyright information

© Biomedical Engineering Society 2008